In fact, there is preclinical evidence that BV promotes the depletion of intratumoral immunosuppressive CD30+ regulatory T-cells and the expansion of CD8+ T-cells, resulting in immunogenic cell death in tumor cells and possibly enhancing the effects of PD-1 blockade [56,57]. The gene discussed is TNFRSF8; the disease is neoplasm.